Skip to Main Content

+

  • • Painless lump beneath the areola in a man who is usually over the age of 50

    • Nipple discharge, retraction, or ulceration may be present

++

Epidemiology

+

  • • Rare disease, with an incidence only about 1% of that for carcinoma of the female breast

    • Average age of occurrence is about 60 years

    • 75% of males with nipple discharge have a breast carcinoma

    • Increase risk with BrCA-2 mutation

++

Symptoms and Signs

+

  • • Hard, painless breast lump, often beneath the areola

    • Nipple discharge, retraction, erosion, or ulceration

    • May have accompanying gynecomastia

++

Imaging Findings

+

  • • Mass on mammography

+

  • • Blood-borne metastases often present at initial presentation, although may be latent

++

Rule Out

+

  • • Gynecomastia

    • Metastatic cancer from another site

+

  • • History and physical exam

    • Mammography

    • Needle biopsy

+

  • • Modified radical mastectomy is first-line therapy for surgical candidates

    • Surgical candidates chosen by the same criteria as women

    • Irradiation is the first step in treating localized metastases to skin, lymph nodes, or bone that are causing symptoms

    • Tumor hormone receptor status may be of benefit in determining role of adjuvant biochemotherapy

    • Castration is possible palliative measure for advanced metastatic disease

++

Medications

+

  • • Tamoxifen for metastatic disease

    • Potential role of aminoglutethimide to suppress adrenal androgen production (has replaced adrenalectomy)

++

Prognosis

+

  • • Worse prognosis, stage for stage, than female breast carcinoma

    • 5- and 10-year survival for stage I cancer is 58% and 38%, respectively

    • 5- and 10-year survival for stage II cancer is 38% and 10%, respectively

    • 5- and 10-year survival rates for all stages combined are 36% and 17%, respectively

++

References

Agrawal A et al: Male breast cancer: a review of clinical management. Breast Cancer Res Treat 2007;103:11.  [PubMed: 17033919]
Fentiman IS et al: Male breast cancer. Lancet 2006;367:595.  [PubMed: 16488803]
Karhu R et al: Large genomic BRCA2 rearrangements and male breast cancer. Cancer Detect Prev 2006;30:530.  [PubMed: 17113724]
Nahleh ZA: Hormonal therapy for male breast cancer: A different approach for a different disease. Cancer Treat Rev 2006;32:101.  [PubMed: 16472925]

++

Practice Guidelines

+

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessSurgery Full Site: One-Year Subscription

Connect to the full suite of AccessSurgery content and resources including more than 160 instructional videos, 16,000+ high-quality images, interactive board review, 20+ textbooks, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessSurgery

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.